Fabienne Rolling
Impact in
- Genetics top 1%
- Virus-based gene therapy research
- Ophthalmology top 1%
- Retinal Diseases and Treatments
Papers in
-
- Retinal Development and Disorders 25
- CRISPR and Genetic Engineering 16
- RNA Interference and Gene Delivery 11
- Genetics 38
- Virus-based gene therapy research 36
- Co-authors
- Philippe Moullier (28 shared papers)Hervé Conrath (4 shared papers)R. Jude Samulski (2 shared papers)Joseph E. Rabinowitz (2 shared papers)Weidong Xiao (1 shared paper)Xiao Xiao (1 shared paper)Chengwen Li (1 shared paper)Knut Stieger (14 shared papers)
- Journals
- Molecular Therapy (14 papers)Gene Therapy (7 papers)Current Gene Therapy (3 papers)Human Gene Therapy (2 papers)PLoS ONE (2 papers)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Fabienne Rolling
52 papers receiving 2.8k citations
Fabienne Rolling's Hit Papers
Peers
Comparison fields: 5 of 84
- Genetics 1.8k
- Ophthalmology 497
- Molecular Biology 2.3k
- Cellular and Molecular Neuroscience 325
- Cardiology and Cardiovascular Medicine 214
Countries citing papers authored by Fabienne Rolling
This map shows the geographic impact of Fabienne Rolling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabienne Rolling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabienne Rolling more than expected).
Fields of papers citing papers by Fabienne Rolling
This network shows the impact of papers produced by Fabienne Rolling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabienne Rolling. The network helps show where Fabienne Rolling may publish in the future.
Co-authors
The 25 scholars most cited alongside Fabienne Rolling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad Specificity Hit paper breakdown → | 2002 | 618 |
| 2 | 2008 | 220 | |
| 3 | 2006 | 159 | |
| 4 | 2003 | 158 | |
| 5 | 2017 | 102 | |
| 6 | 2009 | 89 | |
| 7 | 2006 | 83 | |
| 8 | 2004 | 80 | |
| 9 | 2008 | 74 | |
| 10 | 2004 | 74 | |
| 11 | 2008 | 73 | |
| 12 | 2008 | 67 | |
| 13 | 2002 | 64 | |
| 14 | 2002 | 62 | |
| 15 | 1999 | 54 | |
| 16 | 2013 | 53 | |
| 17 | 2012 | 50 | |
| 18 | 1997 | 50 | |
| 19 | 2003 | 50 | |
| 20 | 1995 | 49 |
About Fabienne Rolling
Fabienne Rolling is a scholar working on Molecular Biology, Genetics, Epidemiology, Ophthalmology and Radiology, Nuclear Medicine and Imaging, having authored 52 papers that have together received 2.8k indexed citations. Recurring topics across this work include Virus-based gene therapy research (36 papers), Retinal Development and Disorders (25 papers), CRISPR and Genetic Engineering (16 papers), RNA Interference and Gene Delivery (11 papers), Herpesvirus Infections and Treatments (10 papers), Retinal Diseases and Treatments (6 papers), Retinal and Optic Conditions (4 papers) and Corneal Surgery and Treatments (3 papers). The work is most often cited by research in Genetics (1.8k citations), Ophthalmology (497 citations), Molecular Biology (2.3k citations), Cellular and Molecular Neuroscience (325 citations) and Cardiology and Cardiovascular Medicine (214 citations). Fabienne Rolling has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Philippe Moullier, Hervé Conrath, R. Jude Samulski, Joseph E. Rabinowitz, Weidong Xiao, Xiao Xiao, Chengwen Li, Knut Stieger, Michel Weber and Yan Chérel. Their work appears in journals such as Molecular Therapy, Gene Therapy, Current Gene Therapy, Human Gene Therapy and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.